Latest Breaking News On - Abliva neuro - Page 1 : comparemela.com

Owl Therapeutics Enters a Strategic Clinical Collaboration With Abliva to Advance NeuroSTAT® (OWL-1410) for Traumatic Brain Injury

/PRNewswire/ Owl Therapeutics, a wholly-owned subsidiary of Gryphon Bio, today announced a global licensing and collaboration agreement with Abliva AB of.